<DOC>
	<DOCNO>NCT00401960</DOCNO>
	<brief_summary>The aim study determine safety efficacy daptomycin use adjuvant agent standard care treatment proven native valve Enterococcal endocarditis . Patients disease offer option receive daptomycin dose 8 milligrams/kilogram/day addition antibiotic already receive . The hypothesis study daptomycin add standard therapy Enterococcal endocarditis safe efficacious . Patients receive daptomycin + standard therapy compare patient receive standard therapy alone respect follow outcome : 1 . Safety . 1 . The frequency Grade 3 4 toxicity ( DAIDS scale ) measure . 2 . The frequency muscle toxicity renal toxicity , determine predefined criterion . 2 . Efficacy . 1 . Clinical efficacy . - Time clearance bacteremia - Cure 6 week follow completion antibiotic therapy - Mortality 6 week follow completion antibiotic therapy 2 . Microbiologic efficacy . - Peak trough serum bactericidal titer - The minimum bactericidal concentration Enterococci daptomycin We expect enroll 40 patient 2 year .</brief_summary>
	<brief_title>Daptomycin Adjuvant Agent Treatment Enterococcal Native Valve Endocarditis .</brief_title>
	<detailed_description />
	<mesh_term>Endocarditis</mesh_term>
	<mesh_term>Endocarditis , Bacterial</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Age 18 Definite Enterococcal endocarditis , define modify Duke criterion Able complete followup 3 6 week follow completion intravenous antibiotic therapy Pregnancy breast feed Creatine phosphokinase level two time upper limit normal Renal insufficiency dialysis requirement . Presence chronic indwell bloodstream catheter foreign body device suspect primary secondary site enterococcal infection unamenable removal replacement Inability discontinue abstain use HMG CoA reductase inhibitor study period . Hypersensitivity study medication . Any condition , investigator 's opinion , may interfere protocol compliance include , limited , active substance abuse and/or dementia . Prosthetic valve endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Enterococcus</keyword>
	<keyword>Daptomycin</keyword>
	<keyword>Endocarditis</keyword>
</DOC>